Skip to main content

Table 3 Summary of the outcomes about fiducial markers implantation and tracking concerning the three main tumor localization: lung, prostate and liver

From: Safety and efficacy of fiducial marker implantation for robotic stereotactic body radiation therapy with fiducial tracking

  Patients treated with SBRT
(n)
Patients treated with fiducial tracking
(n, %)
Fiducial markers implanted (n) Fiducial markers tracked (n) Technical sucess rate
(%)
grade 2 toxicities
(%)
Lung 450 89 (20%) 102 102 100% 2%
Prostate 160 150 (94%) 544 470 91% 0%
Liver 165 151 (92%) 617 461 75% 1%